EIX-Regulation solution strengthens the company's leadership in helping banks and financial institutions stay ahead of regulatory change.
New solution builds on deep expertise with leading banks and financial institutions to strengthen anti-money laundering and compliance efforts
Hybrid AI solutions showcased at ITC Vegas 2025 highlight new capabilities that streamline underwriting, claims and policy servicing for insurers.
Unveiled at BioTechX Europe 2025, the new solutions are purpose-built to accelerate research, clinical trial design and regulatory processes.
ROCKVILLE, Md. , Sept. 30, 2025 /PRNewswire/ -- Expert.ai , a leading provider of enterprise artificial intelligence solutions for business value creation, has been named to the...
Strategic collaboration sets a new standard for accelerating drug development through AI-driven insights.
New solutions to debut at the Online News Association annual conference to showcase the latest digital trends and connect with journalists, leaders and technology innovators shaping the future of media....
Discover 2 compelling AI stocks NVIDIA (NASDAQ: NVDA) has invested in. Learn how the AI leader's vision can guide your portfolio in the tech revolution.
Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...
/AI%20(artificial%20intelligence)/Businessman%20touching%20the%20brain%20working%20of%20Artificial%20Intelligence%20(AI)%20Automation%20by%20Suttiphong%20Chandaeng%20via%20Shutterstock.jpg)
Down over 85% from all-time highs, Recursion Pharmaceuticals is an AI-powered biotech company that aims to accelerate the drug discovery process.